Cargando…

Clinical outcomes of Interleukin-2 therapy in advanced cancer: meta-analysis of over 62 trials

Detalles Bibliográficos
Autores principales:	Coventry, Brendon J, Ashdown, Martin L, Bright, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991084/ http://dx.doi.org/10.1186/2051-1426-1-S1-P149

Ejemplares similares

Mathematical modeling of immune kinetics in advanced cancer through meta-analyses of complete response rates: immune synchronisation emerges as the likely key determinant of clinical response
por: Ashdown, Martin L, et al.
Publicado: (2013)

The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses
por: Coventry, Brendon J, et al.
Publicado: (2012)

Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation
por: Coventry, Brendon J, et al.
Publicado: (2012)

Immune profiling in human breast cancer is predictive of 5- and 10-year survival.
por: Coventry, Brendon, et al.
Publicado: (2015)

Our experience of anti-interleukin 1 therapy
por: Gulez, N, et al.
Publicado: (2015)

Interventions for caries in primary teeth; mapping reported outcomes in clinical trials over the last 30 years
por: Innes, Nicola P T, et al.
Publicado: (2015)

P04.62. Systematic review of clinical studies of whole practice naturopathic medicine
por: Calabrese, C, et al.
Publicado: (2012)

Achieving consensus over the assessment of clinical signs in eczema trials
por: Thomas, Kim S, et al.
Publicado: (2015)

Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates
por: Ashdown, Martin L., et al.
Publicado: (2015)

LPS-induced Pellino3 degradation is mediated by p62-dependent autophagy
por: Heeg, A, et al.
Publicado: (2012)

P62 Impact of the Covid-19 pandemic on the SeaSHeL study
por: Joshi, Nikhil, et al.
Publicado: (2021)

Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma
por: Coventry, Brendon J, et al.
Publicado: (2014)

Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
por: Nguyen, Linh T, et al.
Publicado: (2013)

P02.62. DHEA augmentation strategy for treatment of fatigue and depression: a case presentation
por: Glick, R, et al.
Publicado: (2012)

Combined depletion of interleukin-1 and interleukin-6 does not exceed single depletion of interleukin -1 in TNF-mediated arthritis
por: Hayer, Silvia, et al.
Publicado: (2012)

P05.62. Clinical identification of patient propensities to choose integrative medicine for back pain: results from the SPICER project
por: Aickin, M, et al.
Publicado: (2012)

Complete metastasectomy after high-dose interleukin-2 (HD IL-2) therapy for melanoma
por: Chu, Melinda, et al.
Publicado: (2015)

Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression
por: Broen, JCA, et al.
Publicado: (2010)

Influence of Interleukin-4 and Interleukin-13 on serum immunoglobulin E in house dust mite allergy
por: Panaitescu, Carmen, et al.
Publicado: (2014)

Simultaneous targeting of interleukin-1 and interleukin-18 is required for protection against inflammatory and septic shock
por: Berghe, T Vanden, et al.
Publicado: (2014)

A62 IDENTIFICATION OF SPECIFIC COLONIC DEEP MUSCLE LAYER MACROPHAGES SUBSETS BY THE CD64 (FCΓRI) MARKER
por: Nishihara, Y, et al.
Publicado: (2023)

Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review
por: Bright, Richard J, et al.
Publicado: (2014)

Sepsis electronic surveillance and clinical outcomes: impact over mortality of a sepsis early detection electronic rule implemented in the emergency department
por: Martin-Rico, P, et al.
Publicado: (2014)

P62. Effectiveness of melatonin, IL-25 and siRNA IL-17B in growth control of breast cancer cell lines
por: Bottaro Gelaleti, G, et al.
Publicado: (2014)

Consensus on the need for a hierarchical list of patient-reported pain outcomes for meta-analyses of knee osteoarthritis trials
por: Klokker, Louise, et al.
Publicado: (2015)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Association of mastocytosis with interleukin 31 gene polymorphism
por: Nedoszytko, Boguslaw, et al.
Publicado: (2015)

PA01.62. Mukta-sukti bhasma; nectar for acid peptic disorders, w.s.r to its anti-ulcer activity - an experimental study
por: Sreejith, R
Publicado: (2012)

Long-term survival in advanced melanoma patients using repeated therapies: successive immunomodulation improving the odds?
por: Coventry, Brendon J, et al.
Publicado: (2015)

Interleukin-33 in asthma: insights into pro-inflammatory roles of airway structural cells
por: Préfontaine, D, et al.
Publicado: (2010)

Network meta-analysis of clinical trials of fluid treatments in sepsis demonstrates improved survival with albumin compared with crystalloid and hydroxyethyl starch
por: Bansal, M, et al.
Publicado: (2013)

Interleukin-6 receptor in the recent-onset rheumatoid arthritis
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2011)

Constitutive expression and roles of interleukin-8 in canine hemangiosarcoma
por: Kim, Jong-Hyuk, et al.
Publicado: (2013)

Combination of interleukin-15 and fractionated radiotherapy for cancer treatment
por: Aryankalayil, Joseph, et al.
Publicado: (2014)

Core outcomes for randomized trials and core information for clinical decision-making: implications for outcome selection
por: McNair, Angus, et al.
Publicado: (2015)

Safety and tolerability of virucidal hand rubs: a randomized, double-blind, cross-over trial
por: Conrad, A, et al.
Publicado: (2011)

Understanding the biology and use of TNF therapy in jia-clinical outcomes
por: Lovell, Daniel, et al.
Publicado: (2014)

Our experience with the use of the Interleukin-1 receptor antagonist in the treatment of the patient with CINCA/NOMID syndrome (case study - 5 years of therapy)
por: Vargova, V, et al.
Publicado: (2011)

Anti-interleukin-6 therapy for treatment of high platelet counts in cGMP-dependent protein kinase I gene-targeted mice
por: Zhang, Lin, et al.
Publicado: (2013)

Outcomes and resource use for over 80 year olds admitted to a UK critical care unit after an emergency laparotomy over a 3-year period
por: Banks, V, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e635mpr5toj97v5sj3icliag5g